Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * In previous work, we showed a long-term and concentration-dependent beneficial effect of the non-nucleoside reverse transcriptase inhibitor efavirenz (EFV) on high-density lipoproteins (HDL) in human immunodeficiency virus (HIV)-infected patients. * Furthe...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pereira, S (author)
Outros Autores: Batuca, J (author), Caixas, U (author), Branco, T (author), Delgado-Alves, J (author), Germano, I (author), Lampreia, F (author), Monteiro, E (author)
Formato: article
Idioma:eng
Publicado em: 2011
Assuntos:
Infecção por HIV
Antiretrovirais
Efavirenz
Texto completo:http://hdl.handle.net/10400.10/399
País:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/399

Texto Completo

http://hdl.handle.net/10400.10/399

Registros relacionados